You are here

GSK

The coronavirus vaccine frontrunners have emerged. Here's where they stand

BioPharma Dive

Tue, 06/9/20 - 12:32 pm

Moderna Therapeutics

Cansino Biologics

Oxford BioMedica

Is Moderna Really the Leader in the COVID-19 Vaccine Race?

Motley Fool

Mon, 06/8/20 - 10:36 am

Moderna Therapeutics

Biotech GSK's cell therapy R&D lead jumps ship to partner Immatics

Fierce Biotech

Thu, 06/4/20 - 12:36 pm

GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners

Fierce Pharma

Thu, 05/28/20 - 10:56 am

drug manufacturing

GSK adds to its trove of positive data for multiple myeloma contender as rivals continue to command the spotlight

Endpoints

Wed, 05/27/20 - 10:54 am

antibody-drug conjugate

belantamab mafodotin

Multiple Myeloma

GSK's asthma drug Nucala gets speedy review for rare blood disorder

Endpoints

Wed, 05/27/20 - 10:25 am

hypereosinophilic syndrome

priority review

GSK inks $231M manufacturing deal as Hal Barron anticipates fruitful year for pruned R&D group

Endpoints

Fri, 05/22/20 - 10:48 am

Samsung BioLogics

Mammoth Biosciences, GSK partner on CRISPR-based Covid-19 diagnostic

MedCity News

Wed, 05/20/20 - 12:20 pm

Mammoth Biosciences

Jennifer Doudna

GSK sub’s injectable outperforms Gilead in late-stage PrEP trial

Endpoints

Tue, 05/19/20 - 10:33 am

Gilead Sciences

ViiV Healthcare

More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada

Fierce Pharma

Mon, 05/18/20 - 11:12 am

Gilead Sciences

Former GSK vaccine head Slaoui to lead federal 'Warp Speed' project: reports

Fierce Pharma

Thu, 05/14/20 - 10:54 pm

Operation Warp Speed

federal government

GSK taps experimental arthritis antibody to calm the cytokine storm hitting COVID-19 patients

Fierce Biotech

Thu, 05/7/20 - 10:55 am

monoclonal antibodies

The top pharma companies in social media

Fierce Pharma

Mon, 05/4/20 - 11:02 am

Boehringer Ingelheim

GSK sees 'modest' impact on trials, getting head down for 'busy few months' on COVID-19 work

Fierce Biotech

Thu, 04/30/20 - 10:29 am

clinical trials

GSK widens the market for Zejula as FDA signs off on the PARP inhibitor for use in ovarian cancer patients without BRCA mutations

Endpoints

Wed, 04/29/20 - 10:45 pm

GSK posts middling data from PD-1 Tesaro buyout drug

Fierce Biotech

Fri, 04/24/20 - 11:00 am

clinical trials

endometrial cancer

Sanofi, GSK tie up for COVID-19 vaccine work with eyes on possible 2021 rollout

Fierce Pharma

Tue, 04/14/20 - 10:12 am

GSK, AstraZeneca in talks for joint U.K. COVID-19 diagnostics project: Bloomberg

Fierce Biotech

Tue, 04/7/20 - 10:40 am

GlaxoSmithKline and Vir Biotechnology Jump in Race to Treat and Prevent COVID-19

Motley Fool

Mon, 04/6/20 - 09:38 pm

Vir Biotechnology

GSK allies with Innovax for COVID-19 vaccine R&D project

Fierce Biotech

Fri, 04/3/20 - 12:36 pm

Xiamen Innovax Biotech

Pages